Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Shire

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Shire's 2013 CNS, immunology and metabolic's sales performance.

Shire

Takeda divests over-the-counter and prescription drugs to Stada for $660m

Takeda divests over-the-counter and prescription drugs to Stada for $660m

focus on its five key business areas and takeover of Irish biotech Shire. ... In addition to focusing on its key growth areas, Takeda is completing the divestments to accelerate its acquisition of Shire, which it announced in  2018.

Takeda offloads select portfolio to Acino ahead of Shire takeover

Takeda offloads select portfolio to Acino ahead of Shire takeover According to a statement from Takeda, it will use the cash from the deal to reduce its debts, following its takeover of Shire. ... However, Takeda maintained that Shire will help it grow outside Japan, and increase the company’s pipeline in the process.

Takeda’s HAE drug Takhzyro backed by NICE

Takeda’s HAE drug Takhzyro backed by NICE Like Firazyr and Cinryze, Takhzyro was originally developed by Shire, which has been absorbed by Takeda in a  $63bn takeover.

Takeda makes Crohn’s disease case for subcutaneous Entyvio

Takeda makes Crohn’s disease case for subcutaneous Entyvio Patent expiries and a weak near-term pipeline were the main drivers for Takeda's  $63bn takeover of Shire, which completed in January.

EMA clears Novo Nordisk’s long-acting haemophilia A drug

EMA clears Novo Nordisk’s long-acting haemophilia A drug Takeda’s Shire unit already has a long-acting factor VIII product on the market in Adynovate, as does Sanofi with Eloctate from its recent Bioverativ acquisition, Bayer with Kovaltry, and

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

Infographics